Acasă › Leucemie mieloasă acută › Kentucky
Studii clinice pentru Leucemie mieloasă acută în Kentucky
14 studii pentru Leucemie mieloasă acută caută participanți în Kentucky.
Orașe în Kentucky
Text oficial al studiului (în engleză)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Commonwealth Cancer Center-Corbin, Corbin
- Saint Elizabeth Healthcare Edgewood, Edgewood
- și încă 5
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de la 40 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT05334069Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- University of Kentucky/Markey Cancer Center, Lexington
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
În curs de recrutareFaza 2
Vârste de la 18 la 59 · Toate sexele · Actualizat 28 sept. 2026 · NCT05554393A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- University of Kentucky Markey Cancer Center, Lexington
- UofL Health Brown Cancer Center, Louisville
- Norton Cancer Institute, Louisville
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- University of Kentucky/Markey Cancer Center, Lexington
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT05564390Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- University of Kentucky/Markey Cancer Center, Lexington
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06317649Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06672146Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- University of Kentucky/Markey Cancer Center, Lexington
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
În curs de recrutareFaza 2
Vârste de la 18 la 59 · Toate sexele · Actualizat 22 sept. 2026 · NCT05554406A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
În curs de recrutareFaza 3
6 Months – 21 Years · Toate sexele · Actualizat 17 sept. 2026 · NCT04293562Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
În curs de recrutareFaza 3
Vârste de la 1 la 25 · Toate sexele · Actualizat 4 sept. 2026 · NCT07022678The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
În curs de recrutareFaza 1/2
Până la vârsta de 22 · Toate sexele · Actualizat 25 aug. 2026 · NCT04726241Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
- Norton Children's Hospital, Louisville
În curs de recrutareFaza 3
29 Days – 21 Years · Toate sexele · Actualizat 24 aug. 2026 · NCT05183035Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of Kentucky, Lexington
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 20 aug. 2026 · NCT07007312A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Louisville Hospital - James Brown Cancer Center, Louisville
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 6 iul. 2026 · NCT01351545A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- University of Kentucky Markey Cancer Center, Louisville
- Norton Cancer Institute - St. Matthews, Louisville
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 13 mar. 2026 · NCT05735184Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.